GENEVA, Aug. 7 -- TYRA BIOSCIENCES, INC. filed a patent application (US2026/013183) for “FGFR3 INHIBITORS FOR USE IN A METHOD OF TREATING CHILDREN WITH ACHONDROPLASIA”. With publication no. WO/2026/165305, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/444
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....